Here, we focus on two distinct diffuse large B-cell lymphoma (DLBCL) subtypes with poor prognosis, DLBCLs with biallelic TP53 inactivation and DLBCLs that arise through Richter transformation (RT) from chronic lymphocytic leukemia (CLL). By applying an integrative multi-omics and multi-platform approach we will characterize the molecular landscape of RT DLBCLs and define cell-autonomous and non-cell-autonomous oncogenic determinants and associated survival pathways of both lymphomas. Longitudinal assessment of alterations in CLL and paired RT-DLBCLs and an in vivo insertional mutagenesis screen will provide mechanistic insights into the molecular basis of RT that will guide our modelling and future targeting strategies.
PRINCIPAL INVESTIGATOR
Project Interactions
-
A01
Using autochthonous mouse models of aggressive lymphoma to systematically distill actionable vulnerabilities
Prof. Dr. med. Hans Christian Reinhardt -
A02
The functional role of cytoskeletal dysregulation in activated B cell-like diffuse large B cell lymphoma
Prof. Dr. med. Thomas Oellerich -
A03
LUBAC and its enzymatic activities in the development and therapy of ABC-diffuse large B-cell lymphoma
Prof. Dr. rer. nat. Henning Walczak, Dr. rer. nat. Gianmaria Liccardi -
A04
Role of apoptotic caspases in lymphomagenesis
Prof. Dr. rer. nat. Hamid Kashkar -
A05
Understanding the role of cFLIP in B cell lymphoma pathogenesis
Dr. rer. nat. Alessandro Annibaldi -
B01
LYN kinase as a key regulator in the microenvironmental niche of B cell lymphoid tumors
Prof. Dr. med. Michael Hallek, Dr. rer. nat. Phuong-Hien Nguyen -
B02
Deciphering the role of BIRC3 in lymphomagenesis and resistance to therapy
Dr. rer. nat. Nieves Peltzer, Prof. Dr. med. Christian Pallasch -
B03
The role of ferroptosis in diffuse large B-cell lymphoma subtypes
Prof. Dr. rer. nat. Silvia von Karstedt -
B04
T cell-based mechanisms of immune evasion in aggressive B cell lymphomas
Prof. Dr. med. Dr. rer. nat. Sandrine Sander -
B05
New strategies to improve the efficiency and safety of CAR-T cells for the treatment of B cell lymphoma
Dr. rer. nat. Markus Chmielewski, Prof. Dr. med. Dr. nat. med. Roland Ullrich -
C01
Tumor heterogeneity and genomic instability in classical Hodgkin lymphoma
Prof. Dr. rer. nat. Ralf Küppers -
C02
Harnessing defective DNA repair for the treatment of mantle cell lymphoma
Dr. med. Ron Jachimowicz -
C03
Proteogenomic characterization of mantle cell lymphoma
Prof. Dr. med. Reinhard Büttner, Prof. Dr. med. Thomas Oellerich -
C04
Modeling the clonal evolution of high-risk CLL
Prof. Dr. rer. nat. Martin Peifer, Dr. med. Kirsten Fischer -
Z01
Central administration project
Prof. Dr. med. Michael Hallek -
Z02
Service project: Multiparametric analysis of lymphoma cells and their microenvironment
Prof. Dr. med. Reinhard Büttner, Prof. Dr. med. Thomas Oellerich, Dr. rer. nat. Nieves Peltzer, Dr. med. Lukas Frenzel, Prof. Dr. med. Dr. rer. nat. Michal Schweiger -
Z03
Information infrastructure project (INF): Bioinformatics and Data management
Prof. Dr. rer. nat. Martin Peifer, Dr. rer. nat. Nima Abedpour, Dr. rer. nat. Monica Valencia-Schneider